Agilent Technologies, Inc.

NYSE:A 株式レポート

時価総額:US$36.1b

Agilent Technologies 過去の業績

過去 基準チェック /66

Agilent Technologiesは、平均年間10.6%の収益成長を遂げていますが、 Life Sciences業界の収益は、年間 成長しています。収益は、平均年間11.7% 6.7%収益成長率で 成長しています。 Agilent Technologiesの自己資本利益率は23.9%であり、純利益率は21.7%です。

主要情報

10.6%

収益成長率

12.1%

EPS成長率

Life Sciences 業界の成長21.5%
収益成長率6.7%
株主資本利益率23.9%
ネット・マージン21.7%
次回の業績アップデート25 Nov 2024

最近の業績更新

Agilent Technologies' (NYSE:A) Profits May Not Reveal Underlying Issues

Sep 09
Agilent Technologies' (NYSE:A) Profits May Not Reveal Underlying Issues

Recent updates

Here's Why Agilent Technologies (NYSE:A) Can Manage Its Debt Responsibly

Oct 21
Here's Why Agilent Technologies (NYSE:A) Can Manage Its Debt Responsibly

With EPS Growth And More, Agilent Technologies (NYSE:A) Makes An Interesting Case

Sep 23
With EPS Growth And More, Agilent Technologies (NYSE:A) Makes An Interesting Case

Agilent Technologies' (NYSE:A) Profits May Not Reveal Underlying Issues

Sep 09
Agilent Technologies' (NYSE:A) Profits May Not Reveal Underlying Issues

Agilent: A 'Buy' Due To Growing Biopharma, PFAS, And Semi

Aug 23

A Look At The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)

Aug 14
A Look At The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)

Agilent: Making A Move To Ignite Some Growth

Jul 25

Agilent Technologies (NYSE:A) Has A Pretty Healthy Balance Sheet

Jul 15
Agilent Technologies (NYSE:A) Has A Pretty Healthy Balance Sheet

Is Agilent A Buy Before Earnings? Examining The Pros And Cons

May 23

Should You Investigate Agilent Technologies, Inc. (NYSE:A) At US$154?

May 22
Should You Investigate Agilent Technologies, Inc. (NYSE:A) At US$154?

Subdued Growth No Barrier To Agilent Technologies, Inc.'s (NYSE:A) Price

May 07
Subdued Growth No Barrier To Agilent Technologies, Inc.'s (NYSE:A) Price

These 4 Measures Indicate That Agilent Technologies (NYSE:A) Is Using Debt Reasonably Well

Apr 05
These 4 Measures Indicate That Agilent Technologies (NYSE:A) Is Using Debt Reasonably Well

Agilent Technologies: Cash Flow Returns On Investments And Conventional All Point To A Hold

Mar 12

Agilent Technologies Hit A Homerun

Dec 24

Agilent: A Wide Moat Company Expected To Return To Growth In 2024 (Rating Upgrade)

Dec 08

Agilent Technologies (NYSE:A) Seems To Use Debt Quite Sensibly

Dec 07
Agilent Technologies (NYSE:A) Seems To Use Debt Quite Sensibly

Agilent Technologies: Looking Undervalued Heading Into Earnings

Nov 17

Estimating The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)

Oct 26
Estimating The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)

Agilent: Dips Into GARP Territory, Shares At A Crucial Spot On The Chart

Sep 26

Is It Too Late To Consider Buying Agilent Technologies, Inc. (NYSE:A)?

Sep 08
Is It Too Late To Consider Buying Agilent Technologies, Inc. (NYSE:A)?

Agilent Technologies (NYSE:A) Seems To Use Debt Quite Sensibly

Aug 21
Agilent Technologies (NYSE:A) Seems To Use Debt Quite Sensibly

Calculating The Fair Value Of Agilent Technologies, Inc. (NYSE:A)

Jul 23
Calculating The Fair Value Of Agilent Technologies, Inc. (NYSE:A)

Agilent Technologies - A Wealth Compounder 30% Below Its Highs

Jul 13

Here's Why We Think Agilent Technologies (NYSE:A) Might Deserve Your Attention Today

Jul 10
Here's Why We Think Agilent Technologies (NYSE:A) Might Deserve Your Attention Today

What Is Agilent Technologies, Inc.'s (NYSE:A) Share Price Doing?

May 28
What Is Agilent Technologies, Inc.'s (NYSE:A) Share Price Doing?

Agilent Technologies Stock: Starting To Look Appealing

May 25

収支内訳

Agilent Technologies の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

NYSE:A 収益、費用、利益 ( )USD Millions
日付収益収益G+A経費研究開発費
31 Jul 246,4971,4131,764456
30 Apr 246,5911,2421,518465
31 Jan 246,7351,2361,553478
31 Oct 236,8331,2401,578481
31 Jul 236,9941,1331,281486
30 Apr 237,0401,3511,579484
31 Jan 236,9301,3231,585473
31 Oct 226,8481,2541,578467
31 Jul 226,6591,3281,552464
30 Apr 226,5271,2631,548461
31 Jan 226,4451,2051,571455
31 Oct 216,3191,2101,562441
31 Jul 216,1429901,562426
30 Apr 215,8179251,464405
31 Jan 215,5308101,404396
31 Oct 205,3397191,395397
31 Jul 205,2236911,377398
30 Apr 205,2366831,446407
31 Jan 205,2367641,405406
31 Oct 195,1631,0711,358404
31 Jul 195,0901,0721,343406
30 Apr 195,0191,1171,290402
31 Jan 194,9871,1401,301395
31 Oct 184,9143161,322387
31 Jul 184,8092981,284372
30 Apr 184,7202371,269362
31 Jan 184,6161961,235354
31 Oct 174,4726841,205341
31 Jul 174,3946331,173330
30 Apr 174,3245821,167329
31 Jan 174,2415091,159326
31 Oct 164,2024621,174325
31 Jul 164,1264761,184324
30 Apr 164,0964651,175317
31 Jan 164,0404661,170317
31 Oct 154,0384381,189327
31 Jul 154,0463061,189340
30 Apr 154,0412561,184347
31 Jan 154,0662041,196353
31 Oct 144,0482321,199358
31 Jul 144,7234351,325434
30 Apr 145,3665401,490518
31 Jan 146,1106661,654604

質の高い収益: Aは 高品質の収益 を持っています。

利益率の向上: Aの現在の純利益率 (21.7%)は、昨年(16.2%)よりも高くなっています。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: Aの収益は過去 5 年間で年間10.6%増加しました。

成長の加速: Aの過去 1 年間の収益成長率 ( 24.7% ) は、5 年間の平均 ( 年間10.6%を上回っています。

収益対業界: Aの過去 1 年間の収益成長率 ( 24.7% ) はLife Sciences業界-4.7%を上回りました。


株主資本利益率

高いROE: Aの 自己資本利益率 ( 23.9% ) は 高い とみなされます。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘